Neuroprotective effects of C-type natriuretic peptide on rat retinal ganglion cells

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 7, 2010, Pages 3544-3553

  Ma, Jia ^a,b,c   Yu, Wenhan ^a,c   Wang, Yun ^a   Cao, Guiqun ^a   Cai, Suping ^a   Chen, Xiaoming ^a   Yan, Naihong ^a   Yuan, Yuansheng ^b   Zeng, Hong ^d   Fleenor, Debra L ^d   Liu, Xuyang ^a   Pang, Iok Hou ^d  

^a Ophthalmic Laboratories   (China)

^b SICHUAN UNIVERSITY   (China)

^c KUNMING MEDICAL UNIVERSITY   (China)

^d ALCON RESEARCH LTD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALPAIN; EXCITATORY AMINO ACID; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; PROTEIN BAX; PROTEIN BCL XL; THY 1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; ATRIAL NATRIURETIC FACTOR RECEPTOR; BAX PROTEIN, RAT; BCL2L1 PROTEIN, RAT; MESSENGER RNA; N METHYLASPARTIC ACID; NATRIURETIC FACTOR; NEUROPROTECTIVE AGENT; PROTEIN BCL X;

ADULT ANIMAL; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL DAMAGE; CELL LABELING; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; NEUROPROTECTION; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; THICKNESS; TISSUE SECTION; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CALPAIN; CELL COUNT; CELL SURVIVAL; CELLS, CULTURED; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; MALE; N-METHYLASPARTATE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, C-TYPE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RETINAL GANGLION CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955857330     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-5049     Document Type: Article

References (57)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82: 844-851.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.
3. Whitson JT. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opin Pharmacother. 2007;8:3237-3249.
4. Bautista RD. Glaucomatous neurodegeneration and the concept of neuroprotection. Int Ophthalmol Clin. 1999;39:57-70.
5. Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol. 1994;112:37-44.
6. Chidlow G, Wood JP, Casson RJ. Pharmacological neuroprotection for glaucoma. Drugs. 2007;67:725-759.
7. Lipton SA. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosyla-tion. Curr Drug Targets. 2007;8:621-632.
8. Osborne NN, Wood JP, Chidlow G, et al. Ganglion cell death in glaucoma: what do we really know? Br J Ophthalmol. 1999;83: 980-986.
9. Pang IH, Li B, Clark AF. The pathogenesis of retinal ganglia cell apoptosis induced by glaucoma (in Chinese). Zhong hua Yan Ke Za Zhi. 2004;40:495-499.
10. Pang IH, Li B, Clark AF. The strategies for optic never protection in glaucoma patients (in Chinese). Zhong hua Yan Ke Za Zhi. 2004;40:783-787.
11. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168: 863-870.
12. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev. 2006;27:47-72.
13. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
14. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332:78-81.
15. Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology. 1992;130:229-239.
16. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-328.
17. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides. 2005;26:901-932.
18. Fernandez-Durango R, Nunez DJ, Brown M.J. Messenger RN. As encoding the natriuretic peptides and their receptors are expressed in the eye. Exp Eye Res. 1995;61:723-729.
19. Zhong L, Chu E, Chu J, Chu TC. CNP-induced changes in pHi, cGMP/cAMP and mRNA expression of natriuretic peptide receptors in human trabecular meshwork cells.J OculPharmacol Ther. 2003;19:425-436.
20. Fidzinski P, Salvador-Silva M, Choritz L, Geibel J, Coca-Prados M. Inhibition of NHE-1 Na+/H+ exchanger by natriuretic peptides in ocular nonpigmented ciliary epithelium. Am J Physiol Cell Physiol 2004;287:C655-C663.
21. Wolfensberger TJ, Singer DR, Freegard T, et al. Evidence for a new role of natriuretic peptides: control of intraocular pressure. Br J Ophthalmol. 1994;78:446-448.
22. Crook RB, Chang AT. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells. BiochemJ. 1997;324:49-55.
23. Fernandez-Durango R, Moya FJ, Ripodas A, et al. Type B and type C natriuretic peptide receptors modulate intraocular pressure in the rabbit eye. Eur J Pharmacol. 1999;364:107-113
24. Takashima Y, Taniguchi T, Yoshida M, et al. Ocular hypotension induced by intravitreally injected C-type natriuretic peptide. Exp Eye Res. 1998;66:89-96.
25. Mittag TW, Tormay A, Ortega M, Severin C. Atrial natriuretic peptide (ANP), guanylate cyclase, and intraocular pressure in the rabbit eye. Curr Eye Res. 1987;6:1189-1196.
26. Rollin R, Mediero A, Roldan-Pallares M, Fernandez-Cruz A, Fernandez-Durango R. Natriuretic peptide system in the human retina. Mol Vis. 2004;10:15-22.
27. Cao LH, Yu YC, Zhao JW, Yang XL. Expression of natriuretic peptides in rat Muller cells. Neurosci Lett. 2004;365:176-179
28. Palm DE, Keil LC, Sassani JW, Severs WB. Immunoreactive atrial natriuretic peptide in the retina of rats and rabbits. Brain Res. 1989;504:142-144.
29. Kutty RK, Fletcher RT, Chader GJ, Krishna G. Expression of guanylate cyclase-A mRNA in the rat retina: detection using polymerase chain reaction. Biochem Biophys Res Commun. 1992;182:851-857.
30. Ahmad I, Barnstable CJ. Differential laminar expression of particulate and soluble guanylate cyclase genes in rat retina. Exp Eye Res. 1993;56:51-62.
31. Duda T, Goraczniak RM, Sitaramayya A, Sharma RK. Cloning and expression of an ATP-regulated human retina C-type natriuretic factor receptor guanylate cyclase. Biochemistry. 1993;32:1391-1395
32. Kuribayashi K, Kitaoka Y, Kumai T, et al. Neuroprotective effect of atrial natriuretic peptide against NMDA-induced neurotoxicity in the rat retina. Brain Res. 2006;1071:34-41.
33. Wiggins AK, Shen PJ, Gundlach AL. Atrial natriuretic peptide expression is increased in rat cerebral cortex following spreading depression: possible contribution to sd-induced neuroprotection. Neuroscience. 2003;118:715-726.
34. Fiscus RR, Tu AW, Chew SB. Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells. Neurore-port. 2001;12:185-189.
35. Pang IH, Zeng H, Fleenor DL, Clark AF. Pigment epithelium-derived factor protects retinal ganglion cells. BMC Neurosci. 2007; 8:11.
36. Fuchs C, Forster V, Balse E, Sahel JA, Picaud S, Tessier LH. Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells. Invest Ophthalmol Vis Sci. 2005;46:2983-2991
37. Lam TT, Abler AS, Kwong JM, Tso MO. N-methyl-D-aspartate (NMDA)-induced apoptosis in rat retina. Invest Ophthalmol Vis Sci. 1999;40:2391-2397.
38. Louzada-Junior P, Dias JJ, Santos WF, et al. Glutamate release in experimental ischaemia of the retina: an approach using microdi-alysis. J Neurochem. 1992;59:358-363.
39. Kowluru RA, Engerman RL, Case GL, Kern TS. Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int. 2001;38:385-390.
40. Kim TW, Kang KB, Choung HK, Park KH, Kim DM. Elevated glutamate levels in the vitreous body of an in vivo model of optic nerve ischemia. Arch Ophthalmol. 2000;118:533-536.
41. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med. 1994;330: 613-622.
42. Pang IH, Clark AF. Rodent models for glaucoma retinopathy and optic neuropathy. J Glaucoma. 2007;16:483-505.
43. Levin LA, Peeples P. History of neuroprotection and rationale as a therapy for glaucoma. Am J Manag Care. 2008;14:S11-S14.
44. Sucher NJ, Lipton SA, Dreyer EB. Molecular basis of glutamate toxicity in retinal ganglion cells. Vision Res. 1997;37:3483-3493.
45. Chiu K, Lam TT, Ying Li WW, Caprioli J, Kwong Kwong JM. calpain and N-methyl-D-aspartate (NMDA)-induced excitotoxicity in rat retinas. Brain Res. 2005;1046:207-215.
46. Siliprandi R, Canella R, Carmignoto G, et al. N-methyl-D-aspartate-induced neurotoxicity in the adult rat retina. Vis Neurosci. 1992; 8:567-573.
47. Inomata Y, Hirata A, Yonemura N, et al. Neuroprotective effects of interleukin-6 on NMDA-induced rat retinal damage. Biochem Bio-phys Res Commun. 2003;302:226-232.
48. Laabich A, Li G, Cooper NG. Characterization of apoptosis-genes associated with NMDA mediated cell death in the adult rat retina. Brain Res Mol Brain Res. 2001;91:34-42.
49. Shi J, Jiang Y, Liu X. Neuroprotective effect of erigeron brevisca-pus (vant) hand-mazz on NMDA-induced retinal neuron injury in the rats (in Chinese). Yan Ke Xue Bao. 2004;20:113-117.
50. Kwong JM, Lam TT, Caprioli J. Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-in-duced apoptosis in rat. Brain Res. 2003;970:119-130.
51. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83:731-801.
52. Azuma M, Shearer TR. The role of calcium-activated protease calpain in experimental retinal pathology. Surv Ophthalmol. 2008; 53:150-163.
53. McKernan DP, Guerin MB, ÓBrien CJ, Cotter TG. A key role for calpains in retinal ganglion cell death. Invest Ophthalmol Vis Sci. 2007;48:5420-5430.
54. Levin LA, Schlamp CL, Spieldoch RL, Geszvain KM, Nickells RW. Identification of the bcl-2 family of genes in the rat retina. Invest Ophthalmol Vis Sci. 1997;38:2545-2553.
55. Adamus G, Webb S, Shiraga S, Duvoisin RM. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun. 2006;26:146-153.
56. Jin Y, Zhong YM, Yang XL. Natriuretic peptides are localized to rat retinal amacrine cells. Neurosci Lett. 2007;421:106-109.
57. Cao LH, Yang XL. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol. 2008;84:234-248.